Drugs / bivalent OPV
bivalent OPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03722004 Comparator | Dec 2018 → Dec 2019 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent OPV | “mOPV1 versus bivalent OPV (bOPV).” PMID 37652822 ↗ Aug 2023 |
| Known as | Bivalent oral poliovirus vaccine | “Bivalent oral poliovirus vaccine is a live, attenuated oral poliovirus vaccine that protects against poliovirus types 1 and 3.” NCT03722004 ↗ |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03722004 ↗ |
| Modality | Vaccine | “Bivalent oral poliovirus vaccine is a live, attenuated oral poliovirus vaccine” NCT03722004 ↗ |
| Route | Oral | “Bivalent oral poliovirus vaccine” NCT03722004 ↗ |